The Pharmacokinetics of a Single Dose of Calcitriol Administered Subcutaneously in Continuous Ambulatory Peritoneal Dialysis Patients
Data up to Jan 2025
Total Citations Per Year
Abstract
References (16)
Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.
1984 • 689 citations
Advances in peritoneal dialysis.
2007 • 617 citations
Calcium Carbonate as a Phosphate Binder in Patients with Chronic Renal Failure Undergoing Dialysis
1986 • 389 citations
Intravenous Calcitriol in the Treatment of Refractory Osteitis Fibrosa of Chronic Renal Failure
1989 • 324 citations
Vitamin D and the kidney
1987 • 106 citations
The effects of intraperitoneal calcitriol on calcium and parathyroid hormone
1987 • 69 citations
The parathyroid-calcitriol axis in health and chronic renal failure.
1990 • 69 citations
Oral calcitriol and calcium: Efficient therapy for uremic hyperparathyroidism
1988 • 66 citations
Intestinal synthesis of 24-keto-1,25-dihydroxyvitamin D3. A metabolite formed in vivo with high affinity for the vitamin D cytosolic receptor.
1983 • 60 citations
Use of oral and parenteral calcitriol in the treatment of renal osteodystrophy.
1990 • 58 citations
Pharmacokinetics of Calcitriol in Continuous Ambulatory and Cycling Peritoneal Dialysis Patients
1990 • 56 citations
Lack of a Direct Effect of 1,25-Dihydroxycholecalciferol on Parathyroid Hormone Secretion by Normal Bovine Parathyroid Glands*
1980 • 44 citations
Losses of Calcitriol to Peritoneal Dialysis Bags and Tubing
1989 • 18 citations
Peritoneal dialysis fluid (PDF) C++ and 1,25(OH)2D3 modulate peritoneal macrophage (PM0) antimicrobial activity in CAPD patients.
1990 • 15 citations
Comparative study of two different routes for insulin administration in CAPD diabetic patients. A multicenter study.
1989 • 12 citations
Secondary hyperparathyroidism in CAPD patients: its suppressibility with high doses of calcitriol.
1990 • 3 citations